J&J and University of Queensland to Develop Chronic Pain Drugs Using Spider Venom

Johnson & Johnson and the University of Queensland's Institute of Molecular Bioscience drug development program will co-develop drugs for the treatment of chronic pain using parts of spider venom, according to a Bloomberg Businessweek report.

The development team will use peptides from spider venom, which can block pain, to create drugs. According to Bloomberg Businessweek, the project team will include University of Queensland researchers Paul Alewood and Glenn King.

Related Articles on Pain Management:
Florida Pain Regulations Might Hurt Care for Some Patients in Pain
Scripps Research Institute Scientists Identify Protein that Sends Pain Signals
Pain Physicians: What is the Biggest Challenge Facing Pain Management as a Specialty Right Now?

© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.